$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[미국특허] Immediate release gastrointestinal drug delivery system 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/20
출원번호 US-0694314 (2000-10-24)
발명자 / 주소
  • Lerner, E. Itzhak
  • Flashner, Moshe
  • Penhasi, Adel
출원인 / 주소
  • Dexcel Pharma Technologies Ltd.
대리인 / 주소
    Graeser, D'vorah
인용정보 피인용 횟수 : 85  인용 특허 : 55

초록

A gastrointestinal delivery system is provided. The system comprises a drug in combination with a swellable core material, the core being surrounded by a water-insoluble or relatively water-insoluble coating material in which particulate water-insoluble material is embedded. When the delivery device

대표청구항

A gastrointestinal delivery system is provided. The system comprises a drug in combination with a swellable core material, the core being surrounded by a water-insoluble or relatively water-insoluble coating material in which particulate water-insoluble material is embedded. When the delivery device

이 특허에 인용된 특허 (55) 인용/피인용 타임라인 분석

  1. Silver Frederick A. (Long Valley NJ) Berg Richard A. (Lambertville NJ) Birk David E. (Somerset NJ) Weadock Kevin (Piscataway NJ) Whyne Conrad (Somerset NJ), Biodegradable matrix and methods for producing same.
  2. Bichon Daniel (Gaillard FRX), Biodegradable polypeptide and its use for the gradual release of drugs.
  3. Kelm Gary Robert (Cincinnati OH) Manring Gary Lee (Hamilton OH) Davis Paula Denise (Cincinnati OH) Dobrozsi Douglas Joseph (Loveland OH) Mandel Kenneth Gary (Fairfield OH) McCauley-Meyers David Lee (, Bisacodyl dosage form for colonic delivery.
  4. Kelm Gary Robert (Cincinnati OH) Manring Gary Lee (Hamilton OH) Davis Paula Denise (Cincinnati OH) Dobrozsi Douglas Joseph (Loveland OH) Mandel Kenneth Gary (Fairfield OH), Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery.
  5. Sintov Amnon (Jerusalem ILX) Rubinstein Abraham (Jerusalem ILX), Colonic drug delivery system.
  6. Zeitoun Paul (Reims FRX) Brisard Patrick (Paris FRX), Compressed tablets for disintegration in the colon comprising an active ingredient containing nucleus coated with a firs.
  7. Ambegaonkar Anil S. (Hatfield PA) Howells Roger A. (Orefield PA), Controlled release delivery coating formulation for bioactive substances.
  8. Jain Nemichand B. (Monmouth Junction NJ) Gertie Linda P. (Cinnaminson NJ) Rudnic Edward M. (Plainsboro NJ), Controlled release formulation.
  9. Kronenthal Richard L. (Fair Lawn NJ) Mattei Frank V. (Piscataway NJ) Levy Alan J. (Bridgewater NJ), Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition.
  10. Weiss Aaron L. (E. Brunswick NJ) Walton Richard W. (Langhorne PA) de Lorimier Albert E. (E. Brunswick NJ), Controlled release tablet.
  11. Bauer Kurt Heinz (Freiburg DEX) Betzing Juergen (Aachen DEX), Crosslinked polysaccharides, process for their preparation and their use.
  12. Habib Yacoub S. ; Shangraw Ralph ; Augsburger Larry L., Cushioning beads and tablet comprising the same capable of forming a suspension.
  13. Hata Takehisa (Nagaokakyo JPX) Kagayama Akira (Ikoma JPX) Kimura Sumihisa (Kawanishi JPX) Ueda Satoshi (Kawanishi JPX) Murata Saburo (Takarazuka JPX), Delayed action preparation.
  14. Theeuwes Felix (Los Altos CA) Guittard George V. (Cupertino CA) Wong Patrick S. L. (Hayward CA), Delivery of drug to colon by oral disage form.
  15. Raaf Helmut (Bad Schwalbach DEX) Wagner Helmar R. (Darmstadt Arheilgen DEX), Dental and oral hygiene preparations.
  16. Okada ; Kunihiro ; Itatsuda ; Yoshiharu ; Endoh ; Takeyuki ; Yabuuchi ; Shigeru ; Yokozawa ; Norio, Digital differential analyzer.
  17. Shasha Baruch S. (Peoria IL) Doane William M. (Morton IL) Russell ; deceased Charles R. (late of Peoria IL by Kathleen G. Russell ; heir), Encapsulation by entrapment.
  18. Brendel Klaus (Tucson AZ) Gross Paul (Stockton CA) Pamukcu Rifat (Cincinnati OH), Esters and amides of substituted phenyl and pyridyl amino carboxylates.
  19. Stroetmann Michael (Mnster DEX), Fibrinogen-containing dry preparation, manufacture and use thereof.
  20. Vassiliades Anthony E. (Deerfield IL) Chang Cheng H. (Naperville IL), Formation of microcapsules by interfacial cross-linking, microcapsules produced, and microcapsular dispersion.
  21. Lerner E. Itzhak,ILX ; Flashner Moshe,ILX ; Penhasi Adel,ILX, Gastrointestinal drug delivery system.
  22. Royer Garfield P. (Worthington OH), Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to.
  23. Oppenheim ; Richard Charles ; Marty ; Jennifer Joy ; Speiser ; Peter, Injectable compositions, nanoparticles useful therein, and process of manufacturing same.
  24. Wallace Donald G. (Menlo Park CA) Reihanian Hertsel (San Francisco CA) Pharriss Bruce B. (Palo Alto CA) Braun William G. (Los Altos CA), Injectable implant composition having improved intrudability.
  25. Lerner E. Itzhak,ILX ; Flashner Moshe,ILX ; Penhasi Adel,ILX, Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps.
  26. Yapel ; Jr. Anthony F. (Roseville MN), Magnetically responsive composite microparticle.
  27. Thompson Samuel A. (Wilmington DE), Medical devices containing triggerable disintegration agents.
  28. Teicher Beverly A. (Needham MA) Rausch Carl W. (Medford MA) Hopkins ; 2nd Robert E. (Scituate MA), Method for treating a tumor with a chemotherapeutic agent.
  29. Pamukcu Rifat (Cincinnati OH) Brendel Klaus (Tucson AZ), Method for treating patients with precancerous lesions by administering substituted sulfonyl idenyl acetic and propionic.
  30. Pamukcu Rifat (Cincinnati OH) Brendel Klaus (Tucson AZ), Method for treating patients with precancerous lesions by administering substituted sulfonyl indenyl acetic and propioni.
  31. Henis Jay M. (St. Louis MO) Tripodi Mary K. (Creve Coeur MO) Stimpson Donald I. (Creve Coeur MO), Modified polymeric surfaces and process for preparing same.
  32. Lehmann Klaus (Rossdorf DEX) Kehr-Dreher Ottilie E. E. (Griesheim DEX) Di Pascale Giuseppe (Weiterstadt DEX), Oral dosage unit form.
  33. Deters Joseph C. (Mountain View CA) Theeuwes Felix (Los Altos CA) Mullins Kevin J. (Berkeley CA) Eckenhoff James B. (Los Altos CA), Osmotic capsule.
  34. Cortese Richard (San Jose CA) Theeuwes Felix (Los Altos CA), Osmotic device with hydrogel driving member.
  35. Deutsch David S. (London GBX) Anwar Jamshed (Ilford GBX), Pharmaceutical compositions.
  36. Kelm Gary Robert (Cincinnati OH) Manring Gary Lee (Hamilton OH), Pharmaceutical dosage form for colonic delivery.
  37. Kelm Gary Robert (Cincinnati OH) Manring Gary Lee (Hamilton OH), Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery.
  38. Suzuki Yoshiki (Hino JPX) Ikura Hiroshi (Hino JPX) Noguchi Toshihide (Tokyo JPX) Izumizawa Katsunori (Yokohama JPX) Kinoshita ; deceased Shiro (late of Tokyo JPX by Kimiko Kinoshita ; Atsuhiro Kinosh, Pharmaceutical preparation for remedy of periodontal disease and process for production thereof.
  39. Conte Ubaldo (Busto Arsizio ITX) La Manna Aldo (Pavia ITX) Maggi Lauretta (Pavia ITX), Pharmaceutical tablets releasing the active substance after a definite period of time.
  40. Cioca Gheorghe (Belleview NJ), Process for preparing macromolecular biologically active collagen.
  41. Kaetsu Isao (Takasaki JPX) Yoshida Masaru (Takasaki JPX), Process for producing a multi-layered slow release composite.
  42. Amidon Gordon L. (Ann Arbor MI) Leesman Glen D. (Ann Arbor MI), Pulsatile drug delivery system.
  43. Chen Chih-Ming (Cooper City FL), Pulsatile particles drug delivery system.
  44. Chen Chih-Ming (Cooper City FL), Pulsatile particles drug delivery system.
  45. Dunn James P. (Los Altos CA) Ramesha Chakk S. (San Jose CA) Barnett Jim W. (La Honda CA) Kertesz Denis J. (Mountain View CA) Miller Aaron B. (Sunnyvale CA) Morgans ; Jr. David (Los Altos CA) Sigal C., Pyrrole pyridazine and pyridazinone anti-inflammatory agents.
  46. Scherbring David J. (Edina MN), Self-compensating brake system for a mowing machine.
  47. Mandel Kenneth G. (Fairfield OH), Senna dosage form.
  48. Barr Ian G. (Parkville AUX) Thiel William J. (Parkville AUX), Single dose vaccination system.
  49. Goosen Mattheus F. A. (Toronto CAX) Sun Anthony M. F. (Willowdale CAX), Slow release injectable insulin composition.
  50. Hymes Alan C. (Hopkins MN) Ong Lincoln T. (Minnetonka MN) Persons Garry R. (Edina MN), Sterile improved bandage containing a medicament.
  51. Stella Valentino ; Rajewski Roger A. ; McGinity James W., Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use.
  52. Alderman Daniel A. (Midland MI) Wolford Troy D. (Midland MI), Sustained release dosage form based on highly plasticized cellulose ether gels.
  53. Ueda Yoshio (Kobe JPX) Hata Takehisa (Muko JPX) Yamaguchi Hisami (Nishinomiya JPX) Ueda Satoshi (Kawanishi JPX) Kodani Masateru (Ikeda JPX), Time-controlled explosion systems and processes for preparing the same.
  54. Luck Edward E. (Menlo Park CA) Brown Dennis M. (Menlo Park CA), Treatments employing drug-containing matrices for introduction into cellular lesion areas.
  55. Johnson Lorin K. (Pleasanton CA) Sleisenger Marvin H. (Kentfield CA), Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents.

이 특허를 인용한 특허 (85) 인용/피인용 타임라인 분석

  1. Andremont, Antoine; Huguet, Helene, Colonic delivery of metallo-dependent enzymes.
  2. Fritz, Ulf; Fritz, Olaf; Gordy, Thomas A.; Wojcik, Ronald; Blümmel, Jacques; Küller, Alexander, Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same.
  3. Shailubhai, Kunwar, Compositions useful for the treatment of gastrointestinal disorders.
  4. Staniforth,John; Tobyn,Michael, Delivery of oral drugs.
  5. Ni,Yawei; Yates,Kenneth M., Delivery of physiological agents with in-situ gels comprising anionic polysaccharides.
  6. Cheng, Xiu Xiu; Qi, Xiaohong; Zhang, Guohua; Dixit, Manesh, Diltiazem controlled release formulation and method of manufacture.
  7. Shah, Syed M.; Hassan, Fred, Enteric coated multiparticulate composition with proteinaceous coating for improved storage stability.
  8. Shah, Syed M.; Hassan, Fred, Enteric coated multiparticulate composition with proteinaceous subcoat.
  9. Shah, Syed M.; Hassan, Fred, Enteric coated multiparticulate composition with proteinaceous subcoat.
  10. Shah, Syed M.; Hassan, Daniel; Hassan, Fred, Enteric coated multiparticulate controlled release peppermint oil composition and related methods.
  11. Shah, Syed M.; Hassan, Daniel; Hassan, Fred, Enteric coated multiparticulate controlled release peppermint oil composition and related methods.
  12. Venkatesh, Gopi M.; Vishnupad, Krishna S.; Percel, Phillip J., Extended release dosage forms of propranolol hydrochloride.
  13. Ziegler, Iris; Bartholomäus, Johannes; Redmer, Jessica, Fast release dosage forms for antibiotics.
  14. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  15. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  16. Mapelli, Luigi; Fabiani, Flavio; Boltri, Luigi; Gatti, Paolo; Serratoni, Mauro; Cassanmagnago, Roberto, Fexofenadine microcapsules and compositions containing them.
  17. Banister, Mark; Fanter, Dale L., Fluid metering device.
  18. Porubcan,Randolph Stanley, Formulations to increase in vivo survival of probiotic bacteria and extend their shelf-life.
  19. Porubcan,Randolph Stanley, Formulations to increasesurvival of probiotic bacteria and extend their shelf-life.
  20. Gong, Glen; Pai, Suresh Subraya; Sershen, Scott Robert, Fragmented hydrogels.
  21. Bourgeois, Sandrine; Fattal, Elias; Andremont, Antoine; Couvreur, Patrick, Galenic formulation for colon-targeted delivery of active ingredients.
  22. Bourgeois,Sandrine; Fattal,Elias; Andremont,Antoine; Couvreur,Patrick, Galenic pectinate formulation for colon-targeted delivery of antibiotic-inactivating enzymes and method of use thereof.
  23. Head, Richard; Sanguansri, Luz; Augustin, Mary Ann, Gi track delivery systems.
  24. Ni, Yawei; Yates, Kenneth M.; Zarzycki, Ryszard, High molecular weight, low methoxyl pectins, and their production and uses.
  25. Banister, Mark; Clark, Raymond; Coiner, Erich; Geronov, Yordan M.; McWilliams, Mark D.; Van Veen, Mark A., High surface area polymer actuator with gas mitigating components.
  26. Sershen, Scott Robert; Pai, Suresh Subraya; Gong, Glen, Hydrogel compositions.
  27. Sershen, Scott Robert; Pai, Suresh Subraya; Gong, Glen, Hydrogel compositions.
  28. Sershen, Scott Robert; Pai, Suresh Subraya; Gong, Glen, Hydrogel compositions.
  29. Sershen, Scott Robert; Pai, Suresh Subraya; Gong, Glen, Hydrogel compositions.
  30. Ni, Yawei; Yates, Kenneth M., In-situ gel formation of pectin.
  31. Ohta, Motohiro; Hayakawa, Eiji; Ito, Kunio; Tokuno, Sanji; Morimoto, Kiyoshi; Watanabe, Yasushi, Intrabuccally rapidly disintegrating tablet and a production method of the tablets.
  32. Ohta, Motohiro; Hayakawa, Eiji; Ito, Kunio; Tokuno, Sanji; Morimoto, Kiyoshi; Watanabe, Yasushi, Intrabuccally rapidly disintegrating tablet and a production method of the tablets.
  33. Ohta, Motohiro; Hayakawa, Eiji; Ito, Kunio; Tokuno, Sanji; Morimoto, Kiyoshi; Watanabe, Yasushi, Intrabuccally rapidly disintegrating tablet and a production method of the tablets.
  34. Fritz, Ulf; Fritz, Olaf; Gordy, Thomas A.; Wojcik, Ronald; Blümmel, Jacques; Küller, Alexander, Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same.
  35. Fritz, Ulf; Fritz, Olaf; Gordy, Thomas A.; Wojcik, Ronald; Blümmel, Jacques; Küller, Alexander, Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same.
  36. Harder, Philipp; Fritz, Olaf; Fritz, Ulf, Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same.
  37. Harder, Philipp; Fritz, Olaf; Fritz, Ulf, Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same.
  38. Banister, Mark; Bloom, William G.; Geronov, Yordan M.; McWilliams, Mark D.; Swenson, David; Van Veen, Mark A., Low profile actuator and improved method of caregiver controlled administration of therapeutics.
  39. Simon, David A.; Lent, Mark S.; Singhal, Ruchika; Csavoy, Andrew N., Method and apparatus for optimizing a computer assisted surgical procedure.
  40. Simon, David; Lent, Mark S.; Singhal, Ruchika; Csavoy, Andrew N., Method and apparatus for optimizing a computer assisted surgical procedure.
  41. Simon, David A., Method and apparatus for optimizing a therapy.
  42. Waynik, Jeffrey M.; Csavoy, Andrew N.; Sootsman, Keith; Solar, Matthew S.; Miller, Thomas I., Method and apparatus for positioning a guide relative to a base.
  43. Ueki, Yosuke; Suzuki, Yasuyuki; Fujioka, Satoshi, Method for stabilizing anti-dementia drug.
  44. Ueki, Yosuke; Suzuki, Yasuyuki; Fujioka, Satoshi, Method for stabilizing anti-dementia drug.
  45. Poortinga, Albert Thijs; Trambitas, Daniela Oana; Hofland, Gerard Willem, Microencapsulate and process for the manufacture thereof.
  46. Shah, Syed M.; Hassan, Fred; Hassan, Daniel; Hassan, Sarah, Multiparticulate L-menthol formulations and related methods.
  47. Shah, Syed; Hassan, Daniel; Hassan, Sarah, Multiparticulate L-menthol formulations and related methods.
  48. Shimizu, Toshihiro; Morimoto, Shuji; Tabata, Tetsuro, Orally disintegrable tablets.
  49. Shimizu, Toshihiro; Morimoto, Shuji; Tabata, Tetsuro, Orally disintegrable tablets.
  50. Shimizu,Toshihiro; Morimoto,Shuji; Tabata,Tetsuro, Orally disintegrable tablets.
  51. Venkatesh, Gopi M.; Harmon, Troy M.; Taylor, John, Orally disintegrating tablets of atomoxetine.
  52. Venkata Ramana Rao, Sripriya; Shah, Syed M.; Tatapudy, Hanumantharao; Saunders, Richard William; Fawzi, Mahdi; Nagi, Arwinder; Singh, Shailesh; Hasan, Sumon A, Pantoprazole multiparticulate formulations.
  53. Venkata Ramana Rao, Sripriya; Shah, Syed M.; Tatapudy, Hanumantharao; Saunders, Richard William; Fawzi, Mahdi; Nagi, Arwinder; Singh, Shailesh; Hasan, Sumon A, Pantoprazole multiparticulate formulations.
  54. Venkata Ramana Rao, Sripriya; Shah, Syed M.; Tatapudy, Hanumantharao; Saunders, Richard William; Fawzi, Mahdi; Nagi, Arwinder; Singh, Shailesh; Hasan, Sumon A., Pantoprazole multiparticulate formulations.
  55. Venkata Ramana Rao, Sripriya; Shah, Syed M.; Tatapudy, Hanumantharao; Saunders, Richard William; Fawzi, Mahdi; Nagi, Arwinder; Singh, Shailesh; Hasan, Sumon A., Pantoprazole multiparticulate formulations.
  56. Hessel, Lasse L.; Malling, Jesper; Gudmand-Høyer, Eivind, Particulate fibre composition.
  57. Kolatkar, Gershon; Zisman, Erela, Pharmaceutical composition containing irbesartan.
  58. Kolatkar, Gershon; Zisman, Erela, Pharmaceutical composition containing irbesartan.
  59. Ni, Yawei; Yates, Kenneth M.; Zarzycki, Ryszard, Pharmaceutical compositions comprising aloe pectins, and methods for their production and use.
  60. Gong, Glen; Pai, Suresh Subraya; Sershen, Scott Robert, Polysaccharide based hydrogels.
  61. Shah, Syed M.; Hassan, Fred; Hassan, Daniel; Hassan, Sarah, Preventing whisker growth from an L-menthol composition.
  62. Shimizu,Toshihiro; Sugaya,Masae; Nakano,Yoshinori, Rapidly Disintegrable solid preparation.
  63. Shimizu,Toshihiro; Sugaya,Masae; Nakano,Yoshinori, Rapidly disintegrable solid preparation.
  64. Banister, Mark; Geronov, Yordan; McGrath, Dominic, Smart polymer materials with excess reactive molecules.
  65. Andrews, Steven W.; Aronow, Sean; Blake, James F.; Brandhuber, Barbara J.; Collier, James; Cook, Adam; Haas, Julia; Jiang, Yutong; Kolakowski, Gabrielle R.; McFaddin, Elizabeth A.; McKenney, Megan L.; McNulty, Oren T.; Metcalf, Andrew T.; Moreno, David A.; Ramann, Ginelle A.; Tang, Tony P.; Ren, Li; Walls, Shane M., Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors.
  66. Andrews, Steven W.; Aronow, Sean; Blake, James F.; Brandhuber, Barbara J.; Collier, James; Cook, Adam; Haas, Julia; Jiang, Yutong; Kolakowski, Gabrielle R.; McFaddin, Elizabeth A.; McKenney, Megan L.; McNulty, Oren T.; Metcalf, Andrew T.; Moreno, David A.; Ramann, Ginelle A.; Tang, Tony P.; Ren, Li; Walls, Shane M., Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors.
  67. Andrews, Steven W.; Aronow, Sean; Blake, James F.; Brandhuber, Barbara J.; Cook, Adam; Haas, Julia; Jiang, Yutong; Kolakowski, Gabrielle R.; McFaddin, Elizabeth A.; McKenney, Megan L.; McNulty, Oren T.; Metcalf, Andrew T.; Moreno, David A.; Tang, Tony P.; Ren, Li, Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors.
  68. Andrews, Steven W.; Aronow, Sean; Blake, James F.; Brandhuber, Barbara J.; Cook, Adam; Haas, Julia; Jiang, Yutong; Kolakowski, Gabrielle R.; McFaddin, Elizabeth A.; McKenney, Megan L.; McNulty, Oren T.; Metcalf, Andrew T.; Moreno, David A.; Tang, Tony P.; Ren, Li, Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors.
  69. Andrews, Steven W.; Blake, James F.; Chicarelli, Mark J.; Golos, Adam; Haas, Julia; Jiang, Yutong; Kolakowski, Gabrielle R., Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors.
  70. Andrews, Steven W.; Blake, James F.; Chicarelli, Mark J.; Golos, Adam; Haas, Julia; Jiang, Yutong; Kolakowski, Gabrielle R., Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors.
  71. Andrews, Steven W.; Aronow, Sean; Blake, James F.; Brandhuber, Barbara J.; Cook, Adam; Haas, Julia; Jiang, Yutong; Kolakowski, Gabrielle R.; McFaddin, Elizabeth A.; McKenney, Megan L.; McNulty, Oren T.; Metcalf, Andrew T.; Moreno, David A.; Tang, Tony P.; Ren, Li, Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors.
  72. Andrews, Steven W.; Blake, James F.; Chicarelli, Mark J.; Golos, Adam; Haas, Julia; Jiang, Yutong; Kolakowski, Gabrielle R., Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors.
  73. Andrews, Steven W.; Blake, James F.; Chicarelli, Mark J.; Golos, Adam; Haas, Julia; Jiang, Yutong; Kolakowski, Gabrielle R., Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors.
  74. Grunze, Michael; Fritz, Ulf, Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface.
  75. Banister, Mark; McGrath, Dominic, Super elastic epoxy hydrogel.
  76. Venkatesh, Gopi M., Taste-masked pharmaceutical compositions.
  77. Venkatesh, Gopi M., Taste-masked pharmaceutical compositions.
  78. Venkatesh, Gopi M., Timed, pulsatile release systems.
  79. Venkatesh, Gopi M., Timed, pulsatile release systems.
  80. Venkatesh, Gopi M., Timed, pulsatile release systems.
  81. Venkatesh, Gopi M., Timed, pulsatile release systems.
  82. Venkatesh, Gopi M., Timed, pulsatile release systems.
  83. Percel, Phillip J.; Vishnupad, Krishna S.; Venkatesh, Gopi M., Timed, sustained release systems for propranolol.
  84. Percel, Phillip J.; Vishnupad, Krishna S.; Venkatesh, Gopi M., Timed, sustained release systems for propranolol.
  85. Chase, Kent B.; Smith, Garrick D. S., Wearable drug delivery device having spring drive and sliding actuation mechanism.

활용도 분석정보

상세보기
다운로드
내보내기

활용도 Top5 특허

해당 특허가 속한 카테고리에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로